GW Pharma (GWPH) Updates on Physician Reports from 12-Week Epidiolex Treatment Regime
Tweet Send to a Friend
GW Pharmaceuticals plc (Nasdaq: GWPH) announced physician reports of efficacy and safety data on 27 children and young adults with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
